WPRIM Management System> DCMS> Blood Research> 2016> 51> 4

Volume: 51 Issue: 4

1. Successful treatment of steroid-refractory immune thrombocytopenia with alemtuzumab. Page:297—299
2. Factors associated with vasovagal reactions in apheresis plasma and whole blood donors: a statistical-epidemiological study in a European donor cohort. Page:293—296
3. Steps taken to alleviate under-reporting of transfusion reactions at a public sector hospital in Pakistan. Page:290—292
4. Disseminated cytomegalovirus-associated hemophagocytic lymphohistiocytosis in an elderly patient. Page:288—290
5. Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma. Page:285—287
6. Toxic megacolon and interstitial pneumonia caused by cytomegalovirus infection in a pediatric patient with acute lymphoblastic leukemia receiving chemotherapy. Page:281—285
7. The first case of acute myeloid leukemia with solitary t(6;7)(p21.3;p22) passenger translocation that developed at relapse after allogeneic hematopoietic stem cell transplantation in a patient with a normal karyotype at the initial diagnosis. Page:279—281
8. Allelic variance among ABO blood group genotypes in a population from the western region of Saudi Arabia. Page:274—278
9. Iron deficiency anemia in infants and toddlers. Page:268—273
10. Effect of short-term, high-dose methylprednisolone on oxidative stress in children with acute immune thrombocytopenia. Page:261—267
11. Excellent outcome of medical treatment for Kasabach-Merritt syndrome: a single-center experience. Page:256—260
12. Clinical characteristics and outcomes of varicella zoster virus infection in children with hematologic malignancies in the acyclovir era. Page:249—255
13. Therapy-related myeloid neoplasms in children and adolescents. Page:242—248
14. Mixed-phenotype acute leukemia: suboptimal treatment when the 2008/2016 WHO classification is used. Page:233—241
15. Mesenchymal stromal cells in myeloid malignancies. Page:225—232
16. Emphysematous osteomyelitis due to Escherichia coli in multiple myeloma. Page:224—224
17. Complex cytogenetics in a patient with mixed-phenotype acute leukemia. Page:223—223
18. Salvage treatment of relapsed/refractory LCH. Page:220—222
19. Copper deficiency mimicking myelodysplastic syndrome. Page:217—219
20. Mixed-phenotype acute leukemia (MPAL) and beyond. Page:215—216